Ozempic

(Newser) - A new study suggests the popular weight-loss drug Wegovy might cut the risk of heart disease as well. If the study is confirmed—and it hasn't yet been peer-reviewed—the results could pressure insurers to start covering the pricey drug, reports the New York Times . Maker Novo Nordisk charges...

(Newser) - What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese—and fueled criticism by those who advocate for wider weight acceptance. Soon, it may be...

(Newser) - The FDA is warning consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe. Agency officials said this week that they have received reports of problems after patients used...

(Newser) - Get ready to hear a lot about a weight-loss drug called Mounjaro . Eli Lilly & Co.'s anti-obesity drug has demonstrated significant weight-loss results in clinical trials, so much so that the Wall Street Journal refers to it as the "King Kong" of such drugs. US health regulators...